Molecular Therapeutics Initiative
Accelerating drug discovery at UC Berkeley by bridging academia and biotech to develop next-gen therapeutics for unmet medical needs.
@ucberkeleyofficial.bsky.social
The official account for UC Berkeley. #GoBears 🐻 Main website: https://www.berkeley.edu/ UC Berkeley News: https://news.berkeley.edu/
@robzonculab.bsky.social
Professor of Molecular Therapeutics @ Berkeley-MCB Cofounder of Frontier Medicines Codirector, Molecular Therapeutics Initiative Lysosomes, mTORC1, nutrient signaling, growth regulation, metabolism, autophagy, quality control. www.robertozonculab.org
@micharapelab.bsky.social
Professor and Head of the Division of Molecular Therapeutics in MCB, UC Berkeley Founder, Nurix and Lyterian Therapeutics Excited about stress responses, ubiquitin, proteasome, targeted protein degradation, drug discovery
@berkeleymcb.bsky.social
Molecular & Cell Biology (MCB) Department at UC Berkeley | curiosity driven basic research, education, training and a commitment to public service. 🧪🐻 mcb.berkeley.edu/
@olzmannlab.bsky.social
Professor of Molecular Therapeutics and Metabolic Biology at UC Berkeley; Departments of Molecular & Cell Biology and Nutritional Sciences & Toxicology. Lipid droplets, ferroptosis, ubiquitin, drug development.
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app